World Osteoporosis Day

Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Greece, India, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Norway, Portugal, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom, United States

About

World Osteoporosis Day, observed on October 20, raises awareness about osteoporosis, a condition that weakens bones and increases the risk of fractures. The observance encourages people to learn about bone health, recognize risk factors, and understand the importance of prevention, early detection, and appropriate care.

It is also an opportunity to promote healthy habits that support strong bones throughout life, including regular weight-bearing activity, balanced nutrition, and medical guidance when needed. By sharing information and encouraging conversations with healthcare professionals, World Osteoporosis Day helps communities take practical steps toward healthier, stronger futures.

History

World Osteoporosis Day is observed annually on **October 20** to raise awareness of osteoporosis, a condition in which bones become weaker and more likely to fracture. The observance was launched on **October 20, 1996**, by the European Foundation for Osteoporosis, now known as the International Osteoporosis Foundation (IOF), with support from the European Commission. Its creation reflected growing recognition that osteoporosis was a major public-health issue affecting older adults and that prevention should begin well before the first fracture.

The campaign gained international importance through cooperation with the World Health Organization. In its early years, World Osteoporosis Day focused on explaining the often-silent nature of the disease: many people do not realize they have low bone density until they suffer a fracture. Public education emphasized risk factors such as aging, family history, inadequate calcium and vitamin D, physical inactivity, smoking, and certain medical conditions or treatments. The observance also encouraged people to seek medical advice about bone-health assessment and fracture prevention.

Over time, World Osteoporosis Day developed from a largely European initiative into a global awareness campaign coordinated by the IOF and supported by health organizations, medical professionals, patient groups, and national osteoporosis societies. Each year, activities held around **October 20** commonly include public lectures, screening and risk-assessment events, educational materials, media campaigns, and advocacy for better diagnosis and treatment. Campaign messages have broadened from general awareness to subjects including healthy aging, spinal fractures, hip-fracture prevention, nutrition, exercise, and the importance of identifying osteoporosis before a serious injury occurs.

The observance has cultural significance because it connects personal health choices with a wider social challenge. Osteoporotic fractures can lead to pain, loss of independence, disability, and substantial demands on families and health-care systems. By marking World Osteoporosis Day on **October 20**, communities are encouraged to view bone health as a lifelong concern rather than an issue limited to old age. The day also gives patients and advocacy organizations a platform to call for earlier diagnosis, accessible treatment, and greater public understanding of a disease that is preventable and manageable for many people when addressed in time. Source: [National Today, “World Osteoporosis Day”](https://nationaltoday.com/world-osteoporosis-day/).

Timeline

1994
The World Health Organization published its assessment of fracture risk in postmenopausal women, establishing the bone-mineral-density T-score criteria that became the standard diagnostic definition of osteoporosis.
1995
The U.S. Food and Drug Administration approved alendronate (Fosamax) for treatment of postmenopausal osteoporosis, marking a major drug-therapy milestone.
2010
The U.S. Food and Drug Administration approved denosumab (Prolia) to treat postmenopausal women with osteoporosis at high risk of fracture.

Upcoming dates

Sources

Same day

Related